Sano Chemicals

Sano Chemicals

Open  for investment

About this raise: Sano Chemicals, with a valuation of $50.01 million, is raising funds on StartEngine. The company has developed a breakthrough solution for tackling drug-resistant fungal infections. Sano Chemicals’ flagship product, Occidiofungin, has successfully completed the first part of Phase 1 FDA human trials to treat recurrent vulvovaginal candidiasis and will soon bring innovative treatment to the market. The company has been in talks with pharmaceutical companies and might enter into a license and development agreement after the completion of Phase 2 trials. Timothy Hiebert and Dr. Janice L. Miles founded Sano Chemicals in March 2012. The current crowdfunding campaign has a minimum target of $123,999.48 and a maximum target of $4.9 million. The campaign proceeds will be used for research and development, inventory, company employment, working capital, and marketing.

Expand

Investment Overview

Committed this round: $69,188

Deal Terms

Total Commitments ($USD)

Platform
StartEngine
Start Date
01/10/2025
Close Date
04/10/2025
Min. Goal
$123,999
Max. Goal
$4,999,998
Min. Investment

$494

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$5.43

Pre-Money Valuation

$50,010,300

Company & Team

Company

Year Founded
2012
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B2C
Margin
Medium
Capital Intensity
Low
Location
Bryan, Texas
Business Type
Growth
Company Website
Visit Website

Team

Employees
9
Prior Founder Exits?
No
Founder Name
James Smith
Title
Chairman of the Board of Directors, Co-CEO

Financials

as of November 1, 2024
 Revenue
$0
 Monthly Burn
$20,000
 Runway
7.4 months

Summary Profit and Loss Statement

FY 2023 FY 2022

Revenue

$0

$295,025

COGS

$263,243

$250,759

Tax

$0

$0

 

 

Net Income

$-392,631

$-56,975

Summary Balance Sheet

FY 2023 FY 2022

Cash

$560,124

$465,618

Accounts Receivable

$0

$0

Total Assets

$755,622

$766,195

Short-Term Debt

$68,091

$142,576

Long-Term Debt

$2,056

$45,513

Total Liabilities

$70,147

$188,089

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Company Funding & Growth

Funding history

Total Prior Capital Raised
$743,500
Grants
$115,000
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
04/10/2025 StartEngine $50,010,300 $69,188 Equity - Common Active RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Sano Chemicals on StartEngine 2025
Platform: StartEngine
Security Type: Equity - Common
Valuation: $50,010,300
Price per Share: $5.43

Follow company

Follow Sano Chemicals on StartEngine 2025

Buy Sano Chemicals's Deal Report

Sano Chemicals Deal Report

Get Kingscrowd's comprehensive report on Sano Chemicals including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Sano Chemicals is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Sano Chemicals deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge